← FDA DRUG APPROVALS

FDA ANDA · ANDA079247

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE

Sponsor: NOVEL LABS INC

APPLICATION
ANDA079247
TYPE
ANDA
ORIGINAL APPROVAL
2011-12-30
LATEST ACTION
2011-12-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATEPrescription
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 0.398GM, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 1.102GM · TABLET · ORAL

Approval history

2011-12-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →